Mental Health Repository

INSTITUTION'S PROFILE

Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Publications (9)

Drivers of onward HIV transmission risk among adolescent boys growing up with HIV: a longitudinal cohort study.

Journal: BMJ public health

Publication Year:

Authors & Co-authors: Kidman Rachel R Zhang Xiaoyue X Dietrich Janan Janine JJ Vermaak Stefanie S Ramsammy Candice W CW Madi Phumla P Leshabane Given G Violari Avy A

Drivers of onward HIV transmission risk among adolescent boys growing up with HIV: a longitudinal cohort study.

Journal: BMJ public health

Publication Year:

Authors & Co-authors: Kidman Rachel R Zhang Xiaoyue X Dietrich Janan Janine JJ Vermaak Stefanie S Ramsammy Candice W CW Madi Phumla P Leshabane Given G Violari Avy A

Bisexuality among Men who have Sex with Men in Sub-Saharan Africa: Findings from the HPTN 075 Study.

Journal: AIDS and behavior

Publication Year:

Authors & Co-authors: Ondeng'e Ken K Guo Xu X Mbeda Calvin C Schnabel David D Panchia Ravindre R Dominguez Karen K Dadabhai Sufia S Hamilton Erica L EL Sandfort Theo G M TGM

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors: Bekker Adrie A Capparelli Edmund V EV Violari Avy A Cotton Mark F MF Cababasay Mae M Wang Jiajia J Mathiba Ruth R Wiesner Lubbe L Wiznia Andrew A Samson Pearl P

Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors: Taha Taha E TE Yende-Zuma Nonhlanhla N Brummel Sean S SS Stranix-Chibanda Lynda L Wambuzi Ogwang Lillian L Dadabhai Sufia S Chinula Lameck L Nyati Mandisa M MM Hanley Sherika S Makanani Bonus B

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: Lancet (London, England)

Publication Year: 2021

Authors & Co-authors: Lockman Brummel Ziemba Stranix-Chibanda McCarthy Coletti Jean-Philippe Johnston Krotje Fairlie

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors: Chinula Ziemba Brummel McCarthy Coletti Krotje Johnston Knowles Moyo Stranix-Chibanda

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors: Brooks Kiser Ziemba Ward Rani Cressey Masheto Cassim Deville Ponatshego

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Journal: Lancet (London, England)

Publication Year: 2022

Authors & Co-authors: Delany-Moretlwe Hughes Bock Ouma Hunidzarira Kalonji Kayange Makhema Mandima Mathew